BAK - Braskem S.A. Stock Analysis | Stock Taper
Logo
Braskem S.A.

BAK

Braskem S.A. NYSE
$3.83 1.19% (+0.04)

Market Cap $1.53 B
52w High $4.30
52w Low $2.32
Dividend Yield 3.39%
Frequency Annual
P/E -1.48
Volume 971.81K
Outstanding Shares 398.48M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $17.3B $1.36B $-26M -0.15% $-0.07 $-1.02B
Q2-2025 $17.86B $1.32B $-267M -1.5% $-0.66 $2.36B
Q1-2025 $19.46B $1.21B $698M 3.59% $1.76 $3.26B
Q4-2024 $19.15B $1.45B $-5.65B -29.48% $-14.18 $-1.06B
Q3-2024 $21.27B $1.23B $-593M -2.79% $-1.48 $1.08B

What's going well?

Net loss shrank dramatically, and gross profit improved despite lower sales. Interest expense fell, and there was a big tax benefit this quarter.

What's concerning?

Sales are dropping, expenses are rising, and the company is still losing money at the core business level. Results rely heavily on unusual gains, not real business strength.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $7.41B $87.38B $90.56B $-3.53B
Q2-2025 $10.3B $91.3B $94.56B $-3.81B
Q1-2025 $13.03B $95.42B $99.22B $-4.24B
Q4-2024 $16.77B $101.58B $105.85B $-4.78B
Q3-2024 $14.34B $92.65B $94.14B $-25M

What's financially strong about this company?

They have a large base of real assets, especially in property and equipment. Debt is mostly long-term, giving some breathing room, and inventory is moving rather than piling up.

What are the financial risks or weaknesses?

The company owes more than it owns, with negative equity and high debt levels. Cash reserves are falling, and there’s little cushion if business gets worse.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-26M $-683M $-1.06B $-732M $-2.52B $-1.95B
Q2-2025 $-267M $-285M $-696M $-1.04B $-2.13B $-933M
Q1-2025 $698M $-2.33B $-576M $-191M $-3.67B $-2.98B
Q4-2024 $-8.33B $817M $-1.02B $2.39B $3.07B $-215M
Q3-2024 $-1.31B $-790M $-629M $-637M $-2.29B $-1.63B

What's strong about this company's cash flow?

The company still has $6.66 billion in cash, and working capital changes helped soften the cash burn this quarter.

What are the cash flow concerns?

Cash burn is rising fast, with negative free cash flow of $1.95 billion and no sign of improvement. Cash reserves are dropping and could run out in under a year if trends continue.

Q3 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Braskem S.A.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Braskem benefits from large scale, an integrated production network, and entrenched positions in key chemical and plastics markets. It has shown resilience in keeping EBITDA positive despite a tough environment and has increased its cash reserves. Its innovation agenda—especially around bio-based polymers, recycling, and digital optimization—has given it a differentiated, sustainability-focused profile and strong relationships with major brand owners.

! Risks

The main concerns are financial and cyclical. Profitability has collapsed from earlier highs to substantial losses, with margins under pressure across the board. The balance sheet now carries high and rising debt, negative equity, and deep accumulated losses, which heighten solvency and refinancing risk if conditions remain adverse. Weak and volatile operating and free cash flow, combined with ongoing capital needs, further limit room for error in execution and in macro conditions.

Outlook

The near-term outlook is challenging: returning to consistent profitability and positive free cash flow will likely require both a more favorable industry cycle and internal improvements in cost control, asset utilization, and capital discipline. Over the longer term, Braskem’s leadership in sustainable materials and circular solutions could become a stronger earnings driver if customers and regulators continue to push for greener plastics. Overall, the company sits at a crossroads where strategic strengths and innovation potential are clear, but must be balanced against a currently stressed financial position and elevated uncertainty.